MRNA GoodMoat Verdict
Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.
Moderna Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more. With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.
Current Price
$48.12
+5.25%Profile
Valuation (TTM)
Market Cap$19.00B
P/E-5.95
EV$15.50B
P/B2.20
Shares Out394.94M
P/Sales8.54
Revenue$2.23B
EV/EBITDA—
Moderna Inc (MRNA) Quality Analysis
MRNA Profitability
Profitability trend analysis coming soon
MRNA Growth
Growth trend analysis coming soon
MRNA Financial Health
Financial health indicators coming soon
MRNA Quality & Fundamental Analysis
Moderna Inc (MRNA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. This quality analysis page evaluates Moderna Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Moderna Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of -143.55% and a return on equity (ROE) of -36.92%. Return on assets (ROA) stands at -25.89%.
The debt-to-equity ratio is 0.15, with a current ratio of 3.29. Operating margin is -158.13%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Moderna Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.